Exploring how to make adult skin heal like embryonic skin to improve regeneration and reduce scarring
Investigating the role of Lef1 in fibroblast lineages to induce skin regeneration and reverse aging
This study is looking at how certain skin cells can be changed to help adult skin heal better and without scars, just like baby skin does, which could lead to new treatments for people with scars from burns or surgeries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project ID | NIH-11080761 on NIH RePORTER |
What this research studies
This research investigates the role of specific fibroblast cells in skin regeneration, aiming to understand how to induce adult skin to heal without scarring, similar to how embryonic skin regenerates. The approach involves reprogramming adult fibroblasts using embryonic transcription factors to enhance their regenerative capabilities. By focusing on the differences between adult and embryonic skin healing processes, the research seeks to develop new treatments for various conditions associated with scarring, such as burns and surgical wounds. Patients may benefit from improved healing methods that reduce pain and psychological trauma associated with scars.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults with skin injuries, surgical scars, or conditions that lead to abnormal tissue repair.
Not a fit: Patients with non-skin related conditions or those who do not have issues with scarring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that enhance skin healing and significantly reduce scarring for patients.
How similar studies have performed: While the approach of reprogramming fibroblasts is innovative, similar research has shown promise in regenerative medicine, indicating potential for success.
Where this research is happening
Pullman, United States
- Washington State University — Pullman, United States (Active)
Researchers
- Principal investigator: Driskell, Ryan — Washington State University
- Study coordinator: Driskell, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.